[HTML][HTML] Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes
T John, A Taylor, H Wang, C Eichinger, C Freeman… - Cancer …, 2022 - Elsevier
… clinical understanding of uncommon EGFR mutations, but is the first to systematically
categorise and document both response to EGFR-TKIs and survival in this patient … EGFR-mutated …
categorise and document both response to EGFR-TKIs and survival in this patient … EGFR-mutated …
Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
J Chantharasamee, N Poungvarin, P Danchaivijitr… - BMC cancer, 2019 - Springer
… )-mutant non-small cell lung cancer (NSCLC) is a rare subset of NSCLC. The aim of this … ,
and clinical outcomes of metastatic NSCLC harboring uncommon EGFR mutation at Thailand’s …
and clinical outcomes of metastatic NSCLC harboring uncommon EGFR mutation at Thailand’s …
[HTML][HTML] … and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
S Frega, M Lorenzi, M Fassan, S Indraccolo… - Oncotarget, 2017 - ncbi.nlm.nih.gov
… EGFRm or with rare EGFR mutations not responsive to first-line EGFR TKIs. Analyzed genes
… MassARRAY analysis confirmed EGFR mutations but did not disclose additional mutations. …
… MassARRAY analysis confirmed EGFR mutations but did not disclose additional mutations. …
Clinical outcomes of gefitinib and erlotinib in patients with NSCLC harboring uncommon EGFR mutations: A pooled analysis of 438 patients
C Wang, K Zhao, S Hu, W Dong, Y Gong, M Li, C Xie - Lung Cancer, 2022 - Elsevier
… also assessed outcomes in patients categorized by EGFR-TKIs: (1) gefitinib group; (2) erlotinib
group. Results A total of 438 patients with NSCLC harboring uncommon EGFR mutations …
group. Results A total of 438 patients with NSCLC harboring uncommon EGFR mutations …
[HTML][HTML] Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine …
J Si, X Gu, W Wang, S Ying… - Annals of Palliative …, 2022 - apm.amegroups.org
… EGFR-TKIs. We also found that patients with compound mutations and double uncommon
EGFR mutations … ) than those with single uncommon EGFR mutation, although the difference …
EGFR mutations … ) than those with single uncommon EGFR mutation, although the difference …
[HTML][HTML] Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
A Brindel, W Althakfi, M Barritault, E Watkin… - Journal of Thoracic …, 2020 - ncbi.nlm.nih.gov
… In conclusion, uncommon EGFR mutations may be associated with a poor outcome and the
… in cases of double uncommon mutations and such patients should be treated accordingly. …
… in cases of double uncommon mutations and such patients should be treated accordingly. …
… and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
HA Jung, S Park, JM Sun, SH Lee, JS Ahn, MJ Ahn… - Biology, 2020 - mdpi.com
… EGFR insertion 20 who received EGFR-TKIs as a 1L treatment. We classified patients with
uncommon EGFR mutation into the major uncommon EGFR … Clinical outcomes of the second-…
uncommon EGFR mutation into the major uncommon EGFR … Clinical outcomes of the second-…
Uncommon single and compound EGFR mutations: Clinical outcomes of a heterogeneous subgroup of NSCLC
S Rossi, P Damiano, L Toschi, G Finocchiaro… - Current Problems in …, 2022 - Elsevier
… In addition, our results suggest that point mutations in codon … with other uncommon single
or compound mutations; in our … similar efficacy results in single exon 18 point mutations as …
or compound mutations; in our … similar efficacy results in single exon 18 point mutations as …
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
HY Tu, EE Ke, JJ Yang, YL Sun, HH Yan, MY Zheng… - Lung Cancer, 2017 - Elsevier
… This study reviewed the prevalence of uncommon EGFR mutations and their sensitivity to
EGFR… L858R mutations, indicating that they may benefit from EGFR-TKIs as a first-line therapy. …
EGFR… L858R mutations, indicating that they may benefit from EGFR-TKIs as a first-line therapy. …
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
S Zhou, X Hu, Y Wang, J Li, L Zhou… - … Journal of Clinical …, 2019 - Wiley Online Library
… ), while the rest (referred as uncommon EGFR mutation) have not been fully … investigated
clinical characteristics and outcome of patients with different … 2.2 Clinical outcome assessments …
clinical characteristics and outcome of patients with different … 2.2 Clinical outcome assessments …
相关搜索
- treatment outcomes uncommon egfr mutations
- cell lung cancer uncommon egfr mutations
- tyrosine kinase inhibitors uncommon egfr mutations
- rare egfr mutations clinical consequence
- chinese nsclc patients uncommon egfr mutations
- caucasian patients uncommon egfr mutations
- lung adenocarcinoma patients uncommon egfr mutations
- concurrent genetic alterations uncommon egfr mutations
- erlotinib in patients uncommon egfr mutations
- effectiveness of gefitinib uncommon egfr mutations
- multicenter observational study uncommon egfr mutations
- post hoc analysis uncommon egfr mutations
- systematic literature review uncommon egfr mutations
- cohort study uncommon egfr mutations
- clinical features uncommon egfr mutations
- rare egfr mutations distinct epidemiology